Joshua Moreau lab at OHSU
From Left: Joshua Moreau, Ph.D., Abrar Samiea, Ph.D., George Celis, B.S., and Lauren Rodda, Ph.D., of OHSU. The team works on B cells, traditionally known for antibody production, examining how they influence immune responses and disease progression in areas like inflammation, infections, and cancer. (Courtesy of Joshua Moreau)
Joshua Moreau lab at OHSU
Joshua Moreau, Ph.D., Abrar Samiea, Ph.D., George Celis, B.S., and Lauren Rodda, Ph.D., of OHSU, work on B cells, traditionally known for antibody production, examining how they influence immune responses and disease progression in areas like inflammation, infections, and cancer. (Courtesy of Joshua Moreau)
A medida que las temperaturas bajan en todo el estado, los expertos advierten sobre el riesgo de intoxicación por monóxido de carbono
Review: B cells do more than produce antibodies — they also shape immune responses
Revisión: las células B hacen más que producir anticuerpos, también dan forma a las respuestas inmunes
Científicos de OHSU reciben fondos para investigación innovadora en salud humana
Tres científicos de Oregon Health & Science University han recibido fondos sin restricciones para ampliar sus investigaciones de vanguardia con el objetivo final de mejorar la salud humana. (OHSU/Christine Torres Hicks)
Robert Eil, M.D. (OHSU)
Summer Gibbs, Ph.D. (OHSU)
Renee Ryals, Ph.D. (OHSU)
Private equity firms generate higher professional fees for clinicians study finds
New research finds that private equity firms increase professional fees paid to physicians compared with a control group of practices affiliated with health systems. Co-author Jane Zhu, M.D., says, “Private equity owners appear to be acutely focused on raising these professional fees to the benefit of the practices they acquire. Whether that benefits patients is a yet unanswered question.” (OHSU/Christine Torres Hicks)
